These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 16783197

  • 21. Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model.
    Henderson WR, Lu J, Poole KM, Dietsch GN, Chi EY.
    J Immunol; 2000 Mar 15; 164(6):3360-7. PubMed ID: 10706731
    [Abstract] [Full Text] [Related]

  • 22. Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome.
    Rizos E, Tambaki AP, Gazi I, Tselepis AD, Elisaf M.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Mar 15; 72(3):203-9. PubMed ID: 15664305
    [Abstract] [Full Text] [Related]

  • 23. Platelet-activating factor acetylhydrolase: selective inhibition by potent n-alkyl methylphosphonofluoridates.
    Quistad GB, Fisher KJ, Owen SC, Klintenberg R, Casida JE.
    Toxicol Appl Pharmacol; 2005 Jun 01; 205(2):149-56. PubMed ID: 15893542
    [Abstract] [Full Text] [Related]

  • 24. Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses.
    Henig NR, Aitken ML, Liu MC, Yu AS, Henderson WR.
    Am J Respir Crit Care Med; 2000 Aug 01; 162(2 Pt 1):523-7. PubMed ID: 10934081
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Local expression of platelet-activating factor-acetylhydrolase reduces accumulation of oxidized lipoproteins and inhibits inflammation, shear stress-induced thrombosis, and neointima formation in balloon-injured carotid arteries in nonhyperlipidemic rabbits.
    Arakawa H, Qian JY, Baatar D, Karasawa K, Asada Y, Sasaguri Y, Miller ER, Witztum JL, Ueno H.
    Circulation; 2005 Jun 21; 111(24):3302-9. PubMed ID: 15956136
    [Abstract] [Full Text] [Related]

  • 27. Bovine platelet-activating factor acetylhydrolase (PAF-AH) activity related to fertility.
    Turk R, Juretić D, Geres D, Bacić G, Milesević M, Flegar-Mestrić Z, Turk N, Svetina A.
    Anim Reprod Sci; 2008 May 21; 105(3-4):344-53. PubMed ID: 17442508
    [Abstract] [Full Text] [Related]

  • 28. Plasma platelet-activating factor acetylhydrolase activity in critically ill patients.
    Claus RA, Russwurm S, Dohrn B, Bauer M, Lösche W.
    Crit Care Med; 2005 Jun 21; 33(6):1416-9. PubMed ID: 15942364
    [Abstract] [Full Text] [Related]

  • 29. PAF responsiveness in Japanese subjects with plasma PAF acetylhydrolase deficiency.
    Naoki K, Asano K, Satoh N, Fukunaga K, Oguma T, Shiomi T, Suzuki Y, Nakajima T, Niimi K, Shiraishi Y, Ishizaka A, Yamaguchi K.
    Biochem Biophys Res Commun; 2004 Apr 23; 317(1):205-10. PubMed ID: 15047169
    [Abstract] [Full Text] [Related]

  • 30. Increased susceptibility to septic and endotoxic shock in monocyte chemoattractant protein 1/cc chemokine ligand 2-deficient mice correlates with reduced interleukin 10 and enhanced macrophage migration inhibitory factor production.
    Gomes RN, Figueiredo RT, Bozza FA, Pacheco P, Amâncio RT, Laranjeira AP, Castro-Faria-Neto HC, Bozza PT, Bozza MT.
    Shock; 2006 Nov 23; 26(5):457-63. PubMed ID: 17047515
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical significance of circulating platelet-activating factor acetylhydrolase levels in systemic sclerosis.
    Yanaba K, Asano Y, Tada Y, Sugaya M, Kadono T, Sato S.
    Arch Dermatol Res; 2012 Apr 23; 304(3):203-8. PubMed ID: 22139405
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Treatment of sepsis-induced acquired protein C deficiency reverses Angiotensin-converting enzyme-2 inhibition and decreases pulmonary inflammatory response.
    Richardson MA, Gupta A, O'Brien LA, Berg DT, Gerlitz B, Syed S, Sharma GR, Cramer MS, Heuer JG, Galbreath EJ, Grinnell BW.
    J Pharmacol Exp Ther; 2008 Apr 23; 325(1):17-26. PubMed ID: 18182560
    [Abstract] [Full Text] [Related]

  • 35. Novel mechanism for regulation of plasma platelet-activating factor acetylhydrolase expression in mammalian cells.
    Gardner AA, Reichert EC, Alexander TS, Topham MK, Stafforini DM.
    Biochem J; 2010 May 13; 428(2):269-79. PubMed ID: 20331434
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hepatic regulation of platelet-activating factor acetylhydrolase and lecithin:cholesterol acyltransferase biliary and plasma output in rats exposed to bacterial lipopolysaccharide.
    Svetlov SI, Sturm E, Olson MS, Crawford JM.
    Hepatology; 1999 Jul 13; 30(1):128-36. PubMed ID: 10385648
    [Abstract] [Full Text] [Related]

  • 39. A polymorphism in plasma platelet-activating factor acetylhydrolase is involved in resistance to immunoglobulin treatment in Kawasaki disease.
    Minami T, Suzuki H, Takeuchi T, Uemura S, Sugatani J, Yoshikawa N.
    J Pediatr; 2005 Jul 13; 147(1):78-83. PubMed ID: 16027700
    [Abstract] [Full Text] [Related]

  • 40. [Changes of prostaglandin D2,carboxypeptidase A3 and platelet activating factor in guinea pig in anaphylactic shock].
    Yang K, Guo XJ, Yan XB, Gao CR.
    Fa Yi Xue Za Zhi; 2012 Jun 13; 28(3):175-8. PubMed ID: 22812216
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.